Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aptevo Therapeutics Inc (NQ: APVO )

25.84 USD +0.30 (+1.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,473
Open 25.80
Bid (Size) 25.50 (2)
Ask (Size) 26.20 (2)
Prev. Close 25.54
Today's Range 25.26 - 26.00
52wk Range 5.250 - 60.00
Shares Outstanding 4,449,535
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aptevo Therapeutics Announces Expansion Phase of Lead Anti-Leukemia Drug APVO436 in Adult Patients with Acute Myeloid Leukemia
From ACCESSWIRE
Aptevo Therapeutics Reports Positive Phase 1 Clinical Data for Its Lead Leukemia Drug Candidate APVO436 in Adults With Relapsed Acute Myeloid Leukemia
From ACCESSWIRE

Performance

YTD
-30.51%
-30.51%
1 Month
+17.81%
+17.81%
3 Month
-32.24%
-32.24%
6 Month
-37.91%
-37.91%
1 Year
+380.20%
+380.20%

More News

Read More
Aptevo Therapeutics Reports First Quarter 2021 Financial Results
From ACCESSWIRE
Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
From ACCESSWIRE
Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update
From ACCESSWIRE
Aptevo Confirms Receipt of Nominations and Proposal Notice
From ACCESSWIRE
Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial
From ACCESSWIRE
Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442
From ACCESSWIRE
Aptevo Confirms Receipt of Unsolicited Indication of Interest
From ACCESSWIRE
Looking Into Aptevo Therapeutics's Return On Capital Employed
Tags News BZI/ROCE APVO
From Benzinga
Aptevo Stock Gains on Encouraging Single-Agent Activity for APVO436 In Leukemia Patients
Tags General Market News Health Care
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.